T1	Microorganism 30 44	bifidobacteria
T2	Microorganism 53 65	lactobacilli
T3	Nutrient 0 19	Xylooligosaccharide
T4	INCREASES 20 29	increases
T5	Nutrient 163 192	prebiotic xylooligosaccharide
T6	Nutrient 194 197	XOS
T7	Physiology 227 234;247 249	colonic pH
T8	Metabolite 254 277	short chain fatty acids
T9	Metabolite 279 283	SCFA
T10	AFFECTS 148 155	effects
T11	Population 395 417	Healthy adult subjects
T12	Methodology 447 497	double-blind, randomized, placebo-controlled study
T13	Nutrient 523 526	XOS
T14	Nutrient 534 537	XOS
T15	Biospecimen 657 662	Stool
T16	Methodology 806 813	culture
T17	Methodology 815 846	pyrosequencing of community DNA
T18	Methodology 855 868	SCFA analyses
T19	Physiology 848 850	pH
T20	Physiology 870 879	Tolerance
T21	Methodology 897 917	daily symptom charts
T22	Nutrient 919 922	XOS
T23	INCREASES 1247 1253	higher
T24	Microorganism 988 1003	Bifidobacterium
T25	INCREASES 1011 1020	increased
T26	Nutrient 1029 1032	XOS
T27	Microorganism 1194 1214	Bacteroides fragilis
T28	Microorganism 1341 1354	Lactobacillus
T29	Microorganism 1356 1374	Enterobacteriaceae
T30	Microorganism 1379 1390	Clostridium
T31	Nutrient 1417 1420	XOS
T32	AFFECTS 1441 1459	significant effect
T33	Physiology 1463 1471	stool pH
T34	Metabolite 1473 1477	SCFA
T35	Metabolite 1481 1492	lactic acid
T36	Methodology 1494 1508	Pyrosequencing
T37	Nutrient 1558 1561	XOS
T38	Nutrient 1768 1771	XOS
T39	Physiology 134 143	tolerance
T40	Physiology 848 850	pH
T41	Physiology 927 936	tolerated
T42	Nutrient 1275 1278	XOS
T43	Biospecimen 1463 1468	stool
T44	ASSOCIATED_WITH 1297 1323	no significant differences
T45	INCREASES 49 52	not
E1	INCREASES:T4 Agent:T3 Theme:T1
E2	INCREASES:T45 Agent:T3 Theme:T2
E3	AFFECTS:T10 Agent:T5 Theme:T7
E4	AFFECTS:T10 Agent:T5 Theme:T8
E5	INCREASES:T25 Theme:T24 Agent:T26
E6	AFFECTS:T32 Agent:T31 Theme:T33
E7	AFFECTS:T32 Agent:T31 Theme:T34
E8	AFFECTS:T32 Agent:T31 Theme:T35
E9	INCREASES:T23 Agent:T42 Theme:T27
E10	ASSOCIATED_WITH:T44 Theme:T30 Theme2:T42
E11	ASSOCIATED_WITH:T44 Theme:T29 Theme2:T42
E12	ASSOCIATED_WITH:T44 Theme:T28 Theme2:T42
A1	Factuality E2 Negated
A2	Factuality E3 Unknown
A3	Factuality E4 Unknown
A4	Factuality E6 Negated
A5	Factuality E7 Negated
A6	Factuality E8 Negated
A7	Factuality E10 Negated
A8	Factuality E11 Negated
A9	Factuality E12 Negated
N1	Reference T1 NCBITAXON:1678	Bifidobacterium
N2	Reference T2 NCBITAXON:1578	Lactobacillus
N3	Reference T3 CHEBI:62864	xylooligosaccharide
N4	Reference T5 CHEBI:62864	xylooligosaccharide
N5	Reference T6 CHEBI:62864	xylooligosaccharide
N6	Reference T8 CHEBI:26666	short-chain fatty acid
N7	Reference T9 CHEBI:26666	short-chain fatty acid
N8	Reference T13 CHEBI:62864	xylooligosaccharide
N9	Reference T14 CHEBI:62864	xylooligosaccharide
N10	Reference T19 NCIT:C45997	pH
N11	Reference T20 NCIT:C43414	Tolerance
N12	Reference T22 CHEBI:62864	xylooligosaccharide
N13	Reference T24 NCBITAXON:1678	Bifidobacterium
N14	Reference T26 CHEBI:62864	xylooligosaccharide
N15	Reference T27 NCBITAXON:817	Bacteroides fragilis
N16	Reference T28 NCBITAXON:1578	Lactobacillus
N17	Reference T29 NCBITAXON:543	Enterobacteriaceae
N18	Reference T30 NCBITAXON:1485	Clostridium
N19	Reference T31 CHEBI:62864	xylooligosaccharide
N20	Reference T34 CHEBI:26666	short-chain fatty acid
N21	Reference T35 MESH:D019344	Lactic Acid
N22	Reference T37 CHEBI:62864	xylooligosaccharide
N23	Reference T38 CHEBI:62864	xylooligosaccharide
N24	Reference T39 NCIT:C43414	Tolerance
N25	Reference T40 NCIT:C45997	pH
N26	Reference T41 NCIT:C43414	Tolerance
N27	Reference T42 CHEBI:62864	xylooligosaccharide
